Today, the Bimini group of companies includes Puregraft and Kerastem. Puregraft is the world's market leader in the commercialization of innovative fat transfer tools. Today, Puregraft's products are distributed in over 60 countries worldwide.
Kerastem is a wholly owned subsidiary of Bimini Technologies. In the United States, Kerastem has a focused US FDA Clinical Trial Strategy to enable driving hair growth therapies to market. Kerastem’s solution for female and male pattern baldness is currently in a phase II clinical trial. Kerastem is in parallel actively engaged in market development activities in Europe and Japan.
MANAGEMENT & BOARD
Bradford A. Conlan Chief Executive OfficerMr. Conlan is the co-founder of Bimini Technologies and has served as CEO ...
Bradford A. ConlanMr. Conlan is the co-founder of Bimini Technologies and has served as CEO since 2013. Mr. Conlan has worked in the regenerative medicine space for over 10 years, most recently with Cytori Therapeutics (NASDAQ: CYTX) where he served as the Company’s Director of Global Marketing as well as head of the Regenerative Medicine Business Unit. During his time at Cytori, Mr. Conlan was directly responsible for the research and development of the Celution Cell Therapy platform and Puregraft Fat Transfer products and managed cross functional teams that drove the products from concept to commercialization. Mr. Conlan received a B.S in Biomedical and Industrial Engineering from University of Iowa and a M.S. in Biomedical Engineering from the University of Southern California.
Eric J. Daniels MD, MBA Chief Medical OfficerDr. Eric Daniels currently serves as the Chief Medical Officer of Bimini ...
Eric J. Daniels MD, MBADr. Eric Daniels currently serves as the Chief Medical Officer of Bimini Technologies. Prior to joining Bimini, Dr. Daniels served as the Vice President, Marketing & Sales for Tensys Medical. Tensys is a private equity backed leader in the field of non-invasive hemodynamic monitoring. Prior to Tensys, Dr. Daniels spent 11 years at Cytori Therapeutics, a leading cell-therapy company focused exclusively on adipose tissue. Dr. Daniels served in a variety of roles at Cytori, most recently as the Managing Director-EMEA. Dr. Daniels has published a number of papers on the role of adipose derived regenerative cells. Dr. Daniels holds a Masters of Business Administration from the Anderson School of Management at the University of California, Los Angeles. Dr. Daniels received his Doctor of Medicine degree from the University of California, Los Angeles School of Medicine and his undergraduate degree in Molecular Biology from the University of California, Berkeley.
Richard A. Heise, Jr.Mr. Heise is a veteran entrepreneur having been involved in founding or ...
Richard A. Heise, Jr.Mr. Heise is a veteran entrepreneur having been involved in founding or leadingover a dozen technology and service companies in the past 20 years. Mr. Heise founded InnerWorkings, Inc., which today is a global brand delivery company. He has been primarily occupied as a Private Investor since 1999, including serving as an early investor in Groupon. Mr. Heise also founded Magnitude Network LLC and served as the Chairman & Chief Executive Officer from 1997 to 1998. He founded Magnitude Holdings LLC and served as its Chief Executive Officer from 1996 to 1998 and served as the President of Financial Place Corporation from 1991 to 1995. He has served as the President of Continental Towers Associates and was a Co-Founder and Lead Investor of Rivenet.com. Prior to Rivenet, he was a Co-Founder and Lead Investor of Starbelly. Mr. Heise currently serves as a Director for CareVia, Edge Communications, Swipp and Liquidus, and Bimini Technologies. He previously served as a Director for Echo Global Logistics, Forseva, Aisle Buyer LLC, and MediaBank, LLC. He serves on the Board of Children’s Memorial Hospital in Chicago. Mr. Heise is a Graduate of Harvard University.
James F. ConlanAlong with his brother, Bradford, Jim Conlan co-founded Bimini ...
James F. ConlanAlong with his brother, Bradford, Jim Conlan co-founded Bimini Technologies, Kerastem Technologies, Puregraft LLC, and Aurastem LLC; Jim serves on the Board of Directors, and is the Lead Director, of Bimini, Kerastem, Puregraft, and Aurastem. Jim is also a director of Dubuque Bank & Trust Company, Citizens Finance, and DB&T Insurance. Jim is Co-Chairman of the Firm-wide Corporate Reorganization and Bankruptcy practice of Sidley Austin, and is a member of Sidley's Executive Committee. Jim is also the founder and sole managing member of B&C, LLC, and Conlan Land Development, LLC, which own farm and development land. Jim brings a wealth of business, legal, and capital markets knowledge, experience, and know how to our companies. Jim Conlan is a 1985 graduate of the University Of Iowa (with Honors), and a 1988 graduate of the University of Iowa College Of Law (with Honors).
John J. GasparovicMr. Gasparovic is the Vice president, General Counsel and Secretary of ...
John J. GasparovicMr. Gasparovic is the Vice president, General Counsel and Secretary of BorgWarner Inc. Prior to Borg Warner, he served as Executive Vice President and General Counsel of Roadway Corporation; and VP and General Counsel of Guardian Industries, Automotive Division. Mr Gasparovic also worked for over 8 years at Jones, Day, Reavis and Pogue of Cleveland. Mr. Gasparovic is a graduate of Wayne State University and the Northwestern University School of Law.
Larry NyhanMr. Nyhan is Co-Chairman of the Sidley Austin’s firm-wide Corporate ...